Pure Global AI
NCT06129409Recruiting

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

A Randomized, Double -Blind (Sponsor-Open), Placebo-Controlled Study to Assess the Effect of NT-0796 on Inflammation in Obese Participants at Risk of Cardiovascular Disease
NodThera LimitedPhase 1/2ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Cardiovascular Diseases
Drug/Device/Intervention
NT-0796
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
NodThera Limited
Location
Miami,Austin, United States of America
Timeline & enrollment
Phase
Phase 1/2
Start date
Oct 10, 2023
End date
Apr 01, 2024
Enrollment
69 participants
Primary outcome

Change in hsCRP levels

Summary

This trial is a Randomized, Double-Blind (Sponsor-Open), Placebo-Controlled Study to Assess
 the Effect of NT-0796 on Inflammation in Obese Participants at Risk of Cardiovascular
 Disease.
 
 Participants will be admitted to an in-patient Clinical Research Unit on Day -1 and will be
 discharged on Day 30. The trial will include a 7-day out-patient safety follow-up period
 following the last dose of study treatment.
 
 For the first approximately 20 participants effect of food will be evaluated on the
 Pharmacokinetics of NT-0796. MRI's will be conducted in a subset of participants.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06129409
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06129409 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by NodThera Limited and is currently Recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 69 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.